APA (7th ed.) Citation

VL, S., BZ, G., RM, B., JP, C., A, B., B, N., . . . JB, C. (2025). Atrophin-1 antisense oligonucleotide provides robust protection from pathology in a fully humanized DRPLA model. Molecular therapy. Nucleic acids, 37(1), 102815. https://doi.org/10.1016/j.omtn.2025.102815

Chicago Style (17th ed.) Citation

VL, Smith, et al. "Atrophin-1 Antisense Oligonucleotide Provides Robust Protection from Pathology in a Fully Humanized DRPLA Model." Molecular Therapy. Nucleic Acids 37, no. 1 (2025): 102815. https://doi.org/10.1016/j.omtn.2025.102815.

MLA (9th ed.) Citation

VL, Smith, et al. "Atrophin-1 Antisense Oligonucleotide Provides Robust Protection from Pathology in a Fully Humanized DRPLA Model." Molecular Therapy. Nucleic Acids, vol. 37, no. 1, 2025, p. 102815, https://doi.org/10.1016/j.omtn.2025.102815.